NASDAQ:BYSI

BeyondSpring (BYSI) Stock Price, News & Analysis

$2.11
+0.20 (+10.47%)
(As of 04/22/2024 ET)
Today's Range
$1.92
$2.24
50-Day Range
$1.07
$3.63
52-Week Range
$0.65
$4.00
Volume
63,530 shs
Average Volume
189,359 shs
Market Capitalization
$82.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.25

BeyondSpring MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
Upside/​Downside
40.8% Downside
$1.25 Price Target
Short Interest
Bearish
9.99% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.00 out of 5 stars

Medical Sector

909th out of 909 stocks

Pharmaceutical Preparations Industry

422nd out of 422 stocks

BYSI stock logo

About BeyondSpring Stock (NASDAQ:BYSI)

BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.

BYSI Stock Price History

BYSI Stock News Headlines

BYSI Oct 2024 7.500 call
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
BYSI Mar 2024 7.500 call
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
BeyondSpring Inc BYSI
BeyondSpring Stock (NASDAQ:BYSI) Insider Trades
Oncternal slips after early data for lymphoma therapy
See More Headlines
Receive BYSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BeyondSpring and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/29/2021
Today
4/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:BYSI
Employees
73
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.25
High Stock Price Target
$1.25
Low Stock Price Target
$1.25
Potential Upside/Downside
-40.8%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.35 million
Book Value
($0.36) per share

Miscellaneous

Free Float
27,515,000
Market Cap
$82.12 million
Optionable
Optionable
Beta
0.14
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Dr. Lan Huang Ph.D. (Age 53)
    Co-Founder, Chairman & CEO
  • Mr. Linqing Jia
    Co-Founder
  • Dr. June Lu Ph.D.
    Chief Scientific Officer
  • Stephen Kilmer
    Head of Investor Relations
  • Mr. Gregg Russo
    Senior Vice President of Human Resources

BYSI Stock Analysis - Frequently Asked Questions

What is BeyondSpring's stock price target for 2024?

0 equities research analysts have issued 1 year target prices for BeyondSpring's shares. Their BYSI share price targets range from $1.25 to $1.25. On average, they anticipate the company's share price to reach $1.25 in the next year. This suggests that the stock has a possible downside of 40.8%.
View analysts price targets for BYSI
or view top-rated stocks among Wall Street analysts.

How have BYSI shares performed in 2024?

BeyondSpring's stock was trading at $0.90 at the beginning of 2024. Since then, BYSI shares have increased by 134.4% and is now trading at $2.11.
View the best growth stocks for 2024 here
.

How were BeyondSpring's earnings last quarter?

BeyondSpring Inc. (NASDAQ:BYSI) released its quarterly earnings results on Wednesday, December, 29th. The company reported ($0.47) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.58) by $0.11. The company had revenue of $0.34 million for the quarter, compared to analyst estimates of $0.34 million.

What other stocks do shareholders of BeyondSpring own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BeyondSpring investors own include Exelixis (EXEL), Gilead Sciences (GILD), Sorrento Therapeutics (SRNE), AbbVie (ABBV), Enterprise Products Partners (EPD), Johnson & Johnson (JNJ), Pfizer (PFE), Atara Biotherapeutics (ATRA), Dynavax Technologies (DVAX).

When did BeyondSpring IPO?

BeyondSpring (BYSI) raised $4 million in an IPO on Thursday, March 9th 2017. The company issued 200,000 shares at a price of $20.00 per share. Rodman & Renshaw (a Unit of H.C. Wainwright & Co.) served as the underwriter for the IPO.

How do I buy shares of BeyondSpring?

Shares of BYSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BYSI) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners